// App-Quantinova.ai

e20665 : Liver metastases and sensitivity to checkpoint inhibition in patients with non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Rathi Narayana Pillai

Principal Investigators

  • Alice O. Kamphorst

  • Taofeek Kunle Owonikoko

  • Madhusmita Behera

  • Suchita Pakkala

  • Fadlo Raja Khuri

  • Rafi Ahmed

  • Suresh S. Ramalingam

Medical Centers

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Emory University, Atlanta, GA

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Emory University, Atlanta, GA

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Winship Cancer Institute of Emory University, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Secondary liver cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final